Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA Vaccine Against Tumor Endothelial Marker 8 Inhibits Tumor Angiogenesis and Growth

21 May 2009

Abstract excerpt

Numerous evidences indicated that angiogenesis was a crucial step in the development of tumor, thus the immunotherapy of antiangiogenesis has been involved as potentially relevant candidate targets of cancer immunotherapy. Recently, tumor endothelial marker 8 (TEM8) was discovered to be dominantly expressed in tumor endothelium, which presented a new strategy to antiangiogenesis therapy. However, up to date, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer Research and Treatments
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19609240
DOI: 10.1097/cji.0b013e3181a1d134

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA Vaccine Against Tumor Endothelial Marker 8 Inhibits Tumor Angiogenesis and GrowthPMID 19609240Read ↗

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor MicroenvironmentSemantic proximity Read ↗

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatmentSemantic proximity Read ↗

Cytotoxic T lymphocyte-dependent tumor growth inhibition by a vascular endothelial growth factor-superantigen conjugate.Semantic proximity Read ↗

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapySemantic proximity Read ↗

Immunogene therapy of tumors with vaccine based on <i>Xenopus</i> homologous vascular endothelial growth factor as a model antigenSemantic proximity Read ↗

Modulation of Host Angiogenesis as a Microbial Survival Strategy and Therapeutic TargetSemantic proximity Read ↗

Eps8 vaccine exerts prophylactic antitumor effects in a murine model: a novel vaccine for breast carcinoma.Semantic proximity Read ↗

Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies.Semantic proximity Read ↗

Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.Semantic proximity Read ↗

Tumor suppression through angiogenesis inhibition.Semantic proximity Read ↗

Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivoSemantic proximity Read ↗

A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.